Lyfebulb - A Patient Platform That Embraces and Stimulates Innovation Toward Better Quality of Life
Dr. Karin Hehenberger, is the CEO and Co-Founder of Lyfebulb, an organization whose mission is to "Reduce the burden of chronic disease through the power of the patient."
In our conversation we discussed:
- The origin and goals of Lyfebulb since its inception in 2014.
- How her own diagnosis with Type 1 Diabetes at the age of 16 and subsequent kidney and pancreas transplants impacted her and the mission and goals of Lyfebulb.
- The roles of Patient Ambassadors and Patient Entrepreneurs.
- Why Lyfebulb is a patient-centric organization.
- The upcoming Lyfebulb-Helsinn Innovation Challenge.
- The future of Lyfebulb.
Apply For the Lyfebulb-Helsinn Innovation Challenge - https://lyfebulb.com/innovation-award/helsinn-2019/
Connect With Lyfebulb
Visit their website - https://lyfebulb.com/
Lyfebulb on Instagram - https://instagram.com/lyfebulb
Lyfebulb on Twitter - https://twitter.com/lyfebulb
Lyfebulb on Facebook - https://www.facebook.com/Lyfebulb
Lyfebulb on YouTube - https://www.youtube.com/user/Lyfebulb
WE Have Cancer Links
Subscribe to the show:
Google Podcasts - https://www.google.com/podcasts?feed=aHR0cHM6Ly93ZWhhdmVjYW5jZXJzaG93LmxpYnN5bi5jb20vcnNz
Follow WE Have Cancer on Social Media
Like our Facebook page - https://www.facebook.com/wehavecancershow/
Join our private Facebook group - https://www.facebook.com/groups/wehavecancershow/
Follow us on Twitter - https://twitter.com/wehavecancerpod
Follow us on Instagram - https://instagram.com/wehavecancerpod
Follow us on LinkedIn - https://linkedin.com/company/wehavecancer
Know someone touched by cancer who has an inspiring story?
Nominate a guest to appear on the podcast - https://wehavecancershow.com/guest
Activity